Feedback / Questions
SIRPant-M (SI-101) - SIRPant Immunotherap
https://www.businesswire.com/news/home/20230501005615/en/SIRPant-Immunotherapeutics-Announces-FDA-Clearance-of-IND-Application-for-SIRPant-M%E2%84%A2-Autologous-SIRP%CE%B1low-Activated-Macrophage-Immunotherapy
May 1, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev